Article citationsMore>>

Mackay-Wiggan, J., Jabbari, A., Nguyen, N., Cerise, J.E., Clark, C., Ulerio, G., et al. (2016) Oral Ruxolitinib Induces Hair Regrowth in Patients with Moderate-to-Severe Alopecia Areata. JCI Insight, 1, 1768-1771.
https://doi.org/10.1172/jci.insight.89790

has been cited by the following article:

• TITLE: Understanding Alopecia Areata: Types, Causes, and Latest Therapeutic Approaches

  AUTHORS: Noorah Saleh Al-Sowayan, Asal Khalid AlRebdi, Maryah Khalaf AlMarwani

  KEYWORDS: Genetics, Microorganisms, Stress, Psychological Pressure, Covid 19

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.12 No.11, November 18, 2024

  ABSTRACT: Background: Alopecia areata (AA) is a common autoimmune condition that causes hair loss. Affecting 0.5% - 2% of the population, AA manifests in several types, from mild to severe. Objectives: This study aimed to examine AA’s etiology and innovative treatments of AA, presenting a comprehensive overview of existing and investigational therapies. Methods: We conducted a systematic literature review and screened recent studies to gain insight into treatment efficacy and outcomes. Results: The complexity of AA and the potential for novel therapies enhanced patients’ quality of life. Conclusions: There is a need for further research into AA’s genetic underpinnings of AA and more targeted treatments.